The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Montelukast Sodium Preparations Market Research Report 2024
Synopsis
Global Montelukast Sodium Preparations market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Montelukast Sodium Preparations market research.
Key manufacturers engaged in the Montelukast Sodium Preparations industry include Morepen Laboratories, Mylan, Teva Pharmaceuticals, Merck, Sandoz, Aurobindo Pharma, Otsuka Pharmaceutical, Yangtze River Pharmaceutical (Group) Co., Ltd. and Beijing Winsunny Pharmaceutical Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Montelukast Sodium Preparations were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Montelukast Sodium Preparations market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Montelukast Sodium Preparations market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Morepen Laboratories
Mylan
Teva Pharmaceuticals
Merck
Sandoz
Aurobindo Pharma
Otsuka Pharmaceutical
Yangtze River Pharmaceutical (Group) Co., Ltd.
Beijing Winsunny Pharmaceutical Co., Ltd.
Nanjing Hicin Pharmaceutical Co.,Ltd.
Zhejiang NuoDe Pharmaceutical Co.， Ltd.
Hefei Yingtai Pharmaceutical Co., Ltd.
Lunan Better Pharmaceutical Co., Ltd.
Qilu Pharmaceutical
CSPC Pharmaceutical Group Limited
Segment by Type
Chewable Tablets
Regular Tablet
Particles
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Montelukast Sodium Preparations report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Montelukast Sodium Preparations market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Montelukast Sodium Preparations market research.
Key manufacturers engaged in the Montelukast Sodium Preparations industry include Morepen Laboratories, Mylan, Teva Pharmaceuticals, Merck, Sandoz, Aurobindo Pharma, Otsuka Pharmaceutical, Yangtze River Pharmaceutical (Group) Co., Ltd. and Beijing Winsunny Pharmaceutical Co., Ltd., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Montelukast Sodium Preparations were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Montelukast Sodium Preparations market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Montelukast Sodium Preparations market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Morepen Laboratories
Mylan
Teva Pharmaceuticals
Merck
Sandoz
Aurobindo Pharma
Otsuka Pharmaceutical
Yangtze River Pharmaceutical (Group) Co., Ltd.
Beijing Winsunny Pharmaceutical Co., Ltd.
Nanjing Hicin Pharmaceutical Co.,Ltd.
Zhejiang NuoDe Pharmaceutical Co.， Ltd.
Hefei Yingtai Pharmaceutical Co., Ltd.
Lunan Better Pharmaceutical Co., Ltd.
Qilu Pharmaceutical
CSPC Pharmaceutical Group Limited
Segment by Type
Chewable Tablets
Regular Tablet
Particles
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Montelukast Sodium Preparations report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Montelukast Sodium Preparations Market Overview
1.1 Product Overview and Scope of Montelukast Sodium Preparations
1.2 Montelukast Sodium Preparations Segment by Type
1.2.1 Global Montelukast Sodium Preparations Market Value Comparison by Type (2023-2029)
1.2.2 Chewable Tablets
1.2.3 Regular Tablet
1.2.4 Particles
1.3 Montelukast Sodium Preparations Segment by Application
1.3.1 Global Montelukast Sodium Preparations Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Montelukast Sodium Preparations Market Size Estimates and Forecasts
1.4.1 Global Montelukast Sodium Preparations Revenue 2018-2029
1.4.2 Global Montelukast Sodium Preparations Sales 2018-2029
1.4.3 Global Montelukast Sodium Preparations Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Montelukast Sodium Preparations Market Competition by Manufacturers
2.1 Global Montelukast Sodium Preparations Sales Market Share by Manufacturers (2018-2023)
2.2 Global Montelukast Sodium Preparations Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Montelukast Sodium Preparations Average Price by Manufacturers (2018-2023)
2.4 Global Montelukast Sodium Preparations Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Montelukast Sodium Preparations, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Montelukast Sodium Preparations, Product Type & Application
2.7 Montelukast Sodium Preparations Market Competitive Situation and Trends
2.7.1 Montelukast Sodium Preparations Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Montelukast Sodium Preparations Players Market Share by Revenue
2.7.3 Global Montelukast Sodium Preparations Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Montelukast Sodium Preparations Retrospective Market Scenario by Region
3.1 Global Montelukast Sodium Preparations Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Montelukast Sodium Preparations Global Montelukast Sodium Preparations Sales by Region: 2018-2029
3.2.1 Global Montelukast Sodium Preparations Sales by Region: 2018-2023
3.2.2 Global Montelukast Sodium Preparations Sales by Region: 2024-2029
3.3 Global Montelukast Sodium Preparations Global Montelukast Sodium Preparations Revenue by Region: 2018-2029
3.3.1 Global Montelukast Sodium Preparations Revenue by Region: 2018-2023
3.3.2 Global Montelukast Sodium Preparations Revenue by Region: 2024-2029
3.4 North America Montelukast Sodium Preparations Market Facts & Figures by Country
3.4.1 North America Montelukast Sodium Preparations Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Montelukast Sodium Preparations Sales by Country (2018-2029)
3.4.3 North America Montelukast Sodium Preparations Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Montelukast Sodium Preparations Market Facts & Figures by Country
3.5.1 Europe Montelukast Sodium Preparations Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Montelukast Sodium Preparations Sales by Country (2018-2029)
3.5.3 Europe Montelukast Sodium Preparations Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Montelukast Sodium Preparations Market Facts & Figures by Country
3.6.1 Asia Pacific Montelukast Sodium Preparations Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Montelukast Sodium Preparations Sales by Country (2018-2029)
3.6.3 Asia Pacific Montelukast Sodium Preparations Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Montelukast Sodium Preparations Market Facts & Figures by Country
3.7.1 Latin America Montelukast Sodium Preparations Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Montelukast Sodium Preparations Sales by Country (2018-2029)
3.7.3 Latin America Montelukast Sodium Preparations Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Montelukast Sodium Preparations Market Facts & Figures by Country
3.8.1 Middle East and Africa Montelukast Sodium Preparations Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Montelukast Sodium Preparations Sales by Country (2018-2029)
3.8.3 Middle East and Africa Montelukast Sodium Preparations Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Montelukast Sodium Preparations Sales by Type (2018-2029)
4.1.1 Global Montelukast Sodium Preparations Sales by Type (2018-2023)
4.1.2 Global Montelukast Sodium Preparations Sales by Type (2024-2029)
4.1.3 Global Montelukast Sodium Preparations Sales Market Share by Type (2018-2029)
4.2 Global Montelukast Sodium Preparations Revenue by Type (2018-2029)
4.2.1 Global Montelukast Sodium Preparations Revenue by Type (2018-2023)
4.2.2 Global Montelukast Sodium Preparations Revenue by Type (2024-2029)
4.2.3 Global Montelukast Sodium Preparations Revenue Market Share by Type (2018-2029)
4.3 Global Montelukast Sodium Preparations Price by Type (2018-2029)
5 Segment by Application
5.1 Global Montelukast Sodium Preparations Sales by Application (2018-2029)
5.1.1 Global Montelukast Sodium Preparations Sales by Application (2018-2023)
5.1.2 Global Montelukast Sodium Preparations Sales by Application (2024-2029)
5.1.3 Global Montelukast Sodium Preparations Sales Market Share by Application (2018-2029)
5.2 Global Montelukast Sodium Preparations Revenue by Application (2018-2029)
5.2.1 Global Montelukast Sodium Preparations Revenue by Application (2018-2023)
5.2.2 Global Montelukast Sodium Preparations Revenue by Application (2024-2029)
5.2.3 Global Montelukast Sodium Preparations Revenue Market Share by Application (2018-2029)
5.3 Global Montelukast Sodium Preparations Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Morepen Laboratories
6.1.1 Morepen Laboratories Corporation Information
6.1.2 Morepen Laboratories Description and Business Overview
6.1.3 Morepen Laboratories Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Morepen Laboratories Montelukast Sodium Preparations Product Portfolio
6.1.5 Morepen Laboratories Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Mylan Montelukast Sodium Preparations Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Teva Pharmaceuticals
6.3.1 Teva Pharmaceuticals Corporation Information
6.3.2 Teva Pharmaceuticals Description and Business Overview
6.3.3 Teva Pharmaceuticals Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Teva Pharmaceuticals Montelukast Sodium Preparations Product Portfolio
6.3.5 Teva Pharmaceuticals Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck Montelukast Sodium Preparations Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Sandoz
6.5.1 Sandoz Corporation Information
6.5.2 Sandoz Description and Business Overview
6.5.3 Sandoz Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sandoz Montelukast Sodium Preparations Product Portfolio
6.5.5 Sandoz Recent Developments/Updates
6.6 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Aurobindo Pharma Montelukast Sodium Preparations Product Portfolio
6.6.5 Aurobindo Pharma Recent Developments/Updates
6.7 Otsuka Pharmaceutical
6.6.1 Otsuka Pharmaceutical Corporation Information
6.6.2 Otsuka Pharmaceutical Description and Business Overview
6.6.3 Otsuka Pharmaceutical Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Otsuka Pharmaceutical Montelukast Sodium Preparations Product Portfolio
6.7.5 Otsuka Pharmaceutical Recent Developments/Updates
6.8 Yangtze River Pharmaceutical (Group) Co., Ltd.
6.8.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Corporation Information
6.8.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.8.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Preparations Product Portfolio
6.8.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.9 Beijing Winsunny Pharmaceutical Co., Ltd.
6.9.1 Beijing Winsunny Pharmaceutical Co., Ltd. Corporation Information
6.9.2 Beijing Winsunny Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Beijing Winsunny Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolio
6.9.5 Beijing Winsunny Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Nanjing Hicin Pharmaceutical Co.,Ltd.
6.10.1 Nanjing Hicin Pharmaceutical Co.,Ltd. Corporation Information
6.10.2 Nanjing Hicin Pharmaceutical Co.,Ltd. Description and Business Overview
6.10.3 Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Nanjing Hicin Pharmaceutical Co.,Ltd. Montelukast Sodium Preparations Product Portfolio
6.10.5 Nanjing Hicin Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.11 Zhejiang NuoDe Pharmaceutical Co.， Ltd.
6.11.1 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Corporation Information
6.11.2 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Montelukast Sodium Preparations Description and Business Overview
6.11.3 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Montelukast Sodium Preparations Product Portfolio
6.11.5 Zhejiang NuoDe Pharmaceutical Co.， Ltd. Recent Developments/Updates
6.12 Hefei Yingtai Pharmaceutical Co., Ltd.
6.12.1 Hefei Yingtai Pharmaceutical Co., Ltd. Corporation Information
6.12.2 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Description and Business Overview
6.12.3 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolio
6.12.5 Hefei Yingtai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Lunan Better Pharmaceutical Co., Ltd.
6.13.1 Lunan Better Pharmaceutical Co., Ltd. Corporation Information
6.13.2 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Description and Business Overview
6.13.3 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Preparations Product Portfolio
6.13.5 Lunan Better Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Qilu Pharmaceutical
6.14.1 Qilu Pharmaceutical Corporation Information
6.14.2 Qilu Pharmaceutical Montelukast Sodium Preparations Description and Business Overview
6.14.3 Qilu Pharmaceutical Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Qilu Pharmaceutical Montelukast Sodium Preparations Product Portfolio
6.14.5 Qilu Pharmaceutical Recent Developments/Updates
6.15 CSPC Pharmaceutical Group Limited
6.15.1 CSPC Pharmaceutical Group Limited Corporation Information
6.15.2 CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Description and Business Overview
6.15.3 CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Sales, Revenue and Gross Margin (2018-2023)
6.15.4 CSPC Pharmaceutical Group Limited Montelukast Sodium Preparations Product Portfolio
6.15.5 CSPC Pharmaceutical Group Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Montelukast Sodium Preparations Industry Chain Analysis
7.2 Montelukast Sodium Preparations Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Montelukast Sodium Preparations Production Mode & Process
7.4 Montelukast Sodium Preparations Sales and Marketing
7.4.1 Montelukast Sodium Preparations Sales Channels
7.4.2 Montelukast Sodium Preparations Distributors
7.5 Montelukast Sodium Preparations Customers
8 Montelukast Sodium Preparations Market Dynamics
8.1 Montelukast Sodium Preparations Industry Trends
8.2 Montelukast Sodium Preparations Market Drivers
8.3 Montelukast Sodium Preparations Market Challenges
8.4 Montelukast Sodium Preparations Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
